Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / April / Optogenetic RP Therapy Gains RMAT
Retina Research & Innovations Latest

Optogenetic RP Therapy Gains RMAT

Ray Therapeutics secures FDA RMAT designation for its optogenetic retinitis pigmentosa therapy

4/29/2026 2 min read

Share

  • Full Article
  • Summary
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Top Institutions
Top Institutions in Ophthalmology and Gene Therapy

Leading institutions in this field combine expertise in retinal diseases, gene therapy, optogenetics, and clinical trial development for inherited retinal degenerations. They often lead translational research bridging molecular therapies with clinical applications, including advanced gene delivery techniques and patient-centered outcome measures.

  • #1

    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Massachusetts Eye and Ear is a world leader in retinal disease research and gene therapy clinical trials, with pioneering work in optogenetic approaches and extensive translational programs for inherited retinal degenerations including RP.

    Key Differentiators

    • Ophthalmology
    • Retinal Diseases
    • Gene Therapy
    • Optogenetics
  • #2

    Bascom Palmer Eye Institute, University of Miami

    Miami, FL

    Bascom Palmer is consistently ranked among the top ophthalmology centers globally, with strong clinical and research programs in inherited retinal diseases and gene therapy, including early adoption of novel therapeutic modalities.

    Key Differentiators

    • Ophthalmology
    • Retinal Degeneration
    • Gene Therapy
  • #3

    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Wilmer Eye Institute has a strong translational research program in gene and cell therapies for retinal diseases, including optogenetics, and has contributed to foundational studies in retinal neurobiology and therapy development.

    Key Differentiators

    • Ophthalmology
    • Gene Therapy
    • Retinal Degeneration
  • #4

    University of California, San Francisco (UCSF) Department of Ophthalmology

    San Francisco, CA

    UCSF is recognized for its cutting-edge research in retinal gene therapies and optogenetics, with active clinical trials and collaborations advancing novel treatments for RP and other retinal dystrophies.

    Key Differentiators

    • Ophthalmology
    • Gene Therapy
    • Retinal Degeneration

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: